EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Importance of Fractional Exhaled Nitric Oxide in the Differentiation of Asthma-COPD Overlap (ACO), Asthma and COPD

Muhammad Humayoun Kabir, Md Ezazul Karim, H M Aminur Rashid, Prottush Kumar Mondal, Mohammad Mostafizur Rahman, Abdullah Al Mujahid, S M Abdur Razzaque

Chest & Heart Journal · 18.08.2026 · 47 (2) · 76-85

DOI: 10.3329/chj.v47i2.92705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chest & Heart Journal, online erschienen am 18.08.2026. Verfasst von Muhammad Humayoun Kabir und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic obstructive pulmonary disease (COPD) and asthma are the most common inflammatory airway diseases. Some individuals share features of both asthma and COPD called asthma-COPD overlap (ACO) syndrome (ACOS). Fractional exhaled nitric oxide (FeNO) is an easy, sensitive, reproducible, and noninvasive marker of eosinophilic airway inflammation. Accordingly, FeNO is extensively used to diagnose and manage asthma. Patients with COPD who share some of the features of asthma have a condition called asthma–COPD overlap syndrome (ACOS).

Aims

To evaluate the importance of fractional exhaled nitric oxide (FeNO) in the differentiation of asthma-COPD overlap (ACO), asthma and COPD. Materials & Methods: This cross sectional observational study conducted at the Department of Respiratory Medicine in National Institute of Diseases of the Chest and Hospital from January 2019 to December 2019. A total of 117 patients with asthma-COPD overlap (ACO), asthma and COPD were enrolled in this study. Statistical analyses of the results were obtained by using window based computer software devised with Statistical Packages for Social Sciences (SPSS-23).

Results

Out of 117 patients with asthma-COPD overlap (ACO), asthma and COPD. Out of which 50 patients were asthma, 52 were COPD and 15 were asthma-COPD overlap (ACO) group. Age, sex and BMI were not statistically significant when compared Asthma, COPD and ACO group. However, smoker 12(240%) patients were smoker in asthma group, 48(92.3%) in COPD group and 13(86.7%) in ACO group, that was statistically significant (p

Zitieren

APA

Kabir, M. H., Karim, M. E., Rashid, H. M. A., Mondal, P. K., Rahman, M. M., Mujahid, A. A., & Razzaque, S. M. A. (2026). Importance of Fractional Exhaled Nitric Oxide in the Differentiation of Asthma-COPD Overlap (ACO), Asthma and COPD. Chest & Heart Journal, 47(2), 76-85. https://doi.org/10.3329/chj.v47i2.92705

Vancouver

Kabir MH, Karim ME, Rashid HMA, Mondal PK, Rahman MM, Mujahid AA, et al. Importance of Fractional Exhaled Nitric Oxide in the Differentiation of Asthma-COPD Overlap (ACO), Asthma and COPD. Chest & Heart Journal. 2026;47(2):76-85. doi:10.3329/chj.v47i2.92705

BibTeX
@article{Kabir2026,
  author = {Kabir, Muhammad Humayoun and Karim, Md Ezazul and Rashid, H M Aminur and Mondal, Prottush Kumar and Rahman, Mohammad Mostafizur and Mujahid, Abdullah Al and Razzaque, S M Abdur},
  title = {Importance of Fractional Exhaled Nitric Oxide in the Differentiation of Asthma-COPD Overlap (ACO), Asthma and COPD},
  journal = {Chest & Heart Journal},
  year = {2026},
  volume = {47},
  number = {2},
  pages = {76--85},
  doi = {10.3329/chj.v47i2.92705}
}
Kostenlos starten →